Bibliographic Info
Recommendation
Recommended in favor
Strong
Certainty of evidence
Low
Antiretroviral therapy is recommended for all patients with HIV and drug-resistant TB requiring second-line antituberculosis drugs irrespective of CD4 cell count, as early as possible (within the first 8 weeks) following initiation of antituberculosis treatment
Also Featured In
This recommendation also appears in the following guidelines:
Guidelines for the programmatic management of drug-resistant tuberculosis - 2011 update
WHO guidelines on tuberculosis infection prevention and control: 2019 update
WHO consolidated guidelines on tuberculosis: Module 4: Treatment - Drug-resistant tuberculosis treatment
WHO consolidated guidelines on tuberculosis: module 6: tuberculosis and comorbidities.
WHO consolidated guidelines on tuberculosis: module 4: treatment and care
WHO consolidated guidelines on tuberculosis: module 6: tuberculosis and comorbidities, 2nd ed.
WHO guidelines on the management of advanced HIV disease